TQC2731 injection
TQC2731 injection is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
3
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Clinical Trials (5)
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5